| 股號 / 名稱 | 營收 | 稅後淨利 |
| NVO 諾和諾德 | 393,569,094,933.42 | 133,724,180,378.23 |
| ABT 美國雅培 | 362,260,505,498.64 | 56,145,794,376.96 |
| MDT 美敦力 | 283,289,675,344.56 | 43,690,026,930.72 |
| SYK 史賽克 | 226,701,290,246.16 | 26,839,965,893.04 |
| BSX Boston Scientific Corp | 167,109,610,966.56 | 21,181,127,383.2 |
| PHG Koninklijke Philips NV | 159,608,999,454.87 | 6,975,009,739.08 |
| ZBH Zimmer Biomet Holdings Inc | 63,271,504,992.14 | 7,309,069,628.35 |
| RMD 瑞思邁 | 44,980,115,656.47 | 12,411,287,078.74 |
| QDEL QuidelOrtho Corp | 22,126,374,709.7 | -23,172,785,629.68 |
| NVST Envista Holdings Corp | 21,177,966,020.9 | -957,892,775.69 |
| BIO Bio Rad Laboratories Inc | 20,643,695,792.88 | -10,808,697,690.02 |
| BRBR Bellring Brands Inc | 16,985,999,616.41 | 1,381,515,323.35 |
| ICUI ICU Medical Inc | 16,976,199,393.29 | -58,643,270.59 |
| EYE National Vision Holdings Inc | 15,406,266,877.1 | 106,601,136.62 |
| PAHC Phibro Animal Health Corp | 11,503,976,099.78 | 838,614,576.26 |
| NEOG Neogen Corp | 7,103,296,556.51 | -503,415,332.02 |
| WRBY Warby Parker Inc | 7,008,107,937.77 | 185,698,421.27 |
| TGTX TG Therapeutics Inc | 5,112,207,355.24 | 12,357,607,146.95 |
| ATRC AtriCure Inc | 4,244,729,541.22 | -8,440,837.33 |
| INMD Inmode Ltd | 2,945,283,183.07 | 691,168,638.77 |
| MGNX MacroGenics Inc | 2,302,704,682.78 | 531,804,365.43 |
| VMD Viemed Healthcare Inc | 2,273,462,081.55 | 113,809,042.66 |
| EOLS Evolus Inc | 2,180,296,734.68 | -497,503,584.52 |
| CERS Cerus Corp | 1,904,309,806.24 | -632,272.46 |
| MRVI Maravai LifeSciences Holdings Inc | 1,316,075,123.82 | -1,424,415,009.71 |
| ZVIA Zevia PBC | 1,291,226,816.18 | -90,035,598.19 |
| QTRX Quanterix Corp | 1,271,910,892.55 | -1,059,593,800.75 |
| INFU InfuSystem Holdings Inc | 1,153,517,874.56 | 71,415,174.27 |
| VALN Valneva SE | 1,091,106,709.66 | -1,645,619,983.92 |
| BLFS BioLife Solutions Inc | 887,299,555.62 | 19,632,059.86 |
| XGN Exagen Inc | 545,145,314.32 | -224,045,745.92 |
| RMTI Rockwell Medical Inc | 503,510,172.88 | -55,418,681.05 |
| APYX Apyx Medical Inc | 407,088,622.86 | -61,804,632.89 |
| MYO Myomo Inc | 319,003,585.2 | -115,798,171.81 |
| IMCC IM Cannabis Corp | 314,682,671.57 | -87,809,437.99 |
| UTMD Utah Medical Products Inc | 310,192,868.48 | 83,175,442.01 |
| CTSO Cytosorbents Corp | 299,855,213.78 | -100,215,184.78 |
| ICCC ImmuCell Corp | 174,068,401.65 | -4,418,003.81 |
| NEPH Nephros Inc | 150,607,299.78 | 10,653,790.94 |
| UG United-Guardian Inc | 71,581,461.92 | 8,486,360.95 |
| SNES Senestech Inc | 21,813,399.84 | -41,034,482.6 |
| VERU Veru Inc | 0.0 | 41,228,590.25 |
| CAPR Capricor Therapeutics Inc | 0.0 | -776,767,264.98 |
| CLRB Cellectar Biosciences Inc | 0.0 | -140,487,146.8 |
| PHGE Biomx Inc | 0.0 | -289,770,468.05 |
| ORMP Oramed Pharmaceuticals Inc | 0.0 | 1,529,751,601.41 |
| OMER Omeros Corp | 0.0 | -671,568,192.54 |
| GCTK GlucoTrack Inc | 0.0 | -131,860,421.37 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股營收排名、龍頭是誰?
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例